Publication: Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
No Thumbnail Available
Identifiers
Date
2022-04-02
Authors
Trigo, J.
Cho, B. C.
Park, K.
Girard, N.
Viteri, S.
Garrido, P.
Krebs, M. G.
Thayu, M.
Knoblauch, R. E.
Xie, J.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
